Evogene

EVGN · NASDAQ

$0.3716+$0.0036 (+0.98%)TodayMarket closed · Oct 20, 4:49 PM ET

Prev close $0.368

Latest news

Press releaseOct 20, 8:00 AM ETPRNewswire
Evogene to Participate in U.S. East Coast AI Drug Discovery Roadshow Organized by the Israel Export Institute and TradeIL
Press releaseOct 6, 4:00 PM ETPRNewswire
Evogene and Pure Capital Group Reach Cooperation Agreement to Resolve Differences and Reconstitute Board of Directors
Press releaseSep 30, 7:15 AM ETPRNewswire
Evogene Reports Nasdaq Grants Additional 180-Day Period to Regain Minimum Bid Price Compliance
Press releaseAug 31, 8:00 AM ETPRNewswire
Evogene Responds to Dissident Shareholders: Transformation and Commercial Progress Provide a Clear Path Forward
Press releaseAug 25, 7:00 AM ETPRNewswire
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Evogene Ltd. Shareholders Vote "FOR" the Company's Slate of Highly Qualified Director Nominees
Press releaseAug 18, 8:04 AM ETPRNewswire
Evogene Reports Second Quarter and First Half 2026 Financial Results
Press releaseAug 14, 7:00 AM ETPRNewswire
Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation
NewsAug 10, 8:06 AM ET
12 Health Care Stocks Moving In Monday's Pre-Market Session
Press releaseJul 30, 7:00 AM ETPRNewswire
Evogene Schedules Second Quarter 2026 Financial Results Release
Press releaseJul 22, 8:00 AM ETPRNewswire
Evogene Ltd. and ELEO Inc. Announce Collaboration to Develop Next-Generation Oral Small-Molecule PCSK9 Pathway Inhibitors for Hyperlipidemia and Cardiovascular Diseases
NewsJul 15, 5:05 PM ET
12 Health Care Stocks Moving In Wednesday's After-Market Session
Press releaseJul 15, 7:30 AM ETPRNewswire
AgPlenus Launches Novel AI Model for Predicting Antifungal Potency, Expanding ChemPass AI for Ag™ Capabilities
Press releaseJul 8, 7:00 AM ETPRNewswire
Evogene and Tel Aviv University's Blavatnik Center for Drug Discovery Announce Joint Initiative to Accelerate AI-Driven Small-Molecule Drug Discovery
NewsJun 24, 8:05 AM ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Press releaseJun 24, 8:00 AM ETPRNewswire
Evogene Announces Major Milestone in Its Collaboration with Google Cloud, Advancing ChemPass AI™ Toward Autonomous Small Molecule Discovery and Optimization
NewsJun 11, 6:51 AM ET
Full Transcript: Evogene Q1 2026 Earnings Call
Press releaseJun 9, 7:00 AM ETPRNewswire
Evogene to Present Its Pharma Division Achievements at the BIO International Convention
Press releaseJun 2, 7:00 AM ETPRNewswire
Evogene Announces Successful Completion of Phase 1 Clinical Study of BMC128, a Rationally Designed Live Bacterial Product, in Combination with Nivolumab by its Subsidiary Biomica
NewsMay 20, 7:11 AM ET
Earnings Scheduled For May 20, 2026
Press releaseMay 20, 7:00 AM ETPRNewswire
Evogene Reports First Quarter 2026 Financial Results
Press releaseMay 12, 8:00 AM ETPRNewswire
Evogene to Present at the 24th Schrödinger European User Group Meeting
Press releaseMay 7, 8:00 AM ETPRNewswire
Evogene Schedules First Quarter 2026 Financial Results Release
Press releaseApr 2, 4:01 PM ETPRNewswire
Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification
Press releaseMar 31, 8:00 AM ETPRNewswire
Casterra Announces Successful Commercial Field Trials in Brazil, Positioning Castor Oil as a Promising Candidate for Economically Viable Biofuel Feedstock
Press releaseMar 9, 9:00 AM ETPRNewswire
Evogene to Present Its Pharma Discovery Achievements at BIO-Europe Spring 2026
NewsMar 5, 7:10 AM ET
Evogene Earnings Review: Q4 Summary
Press releaseMar 5, 7:00 AM ETPRNewswire
Evogene Reports Fourth Quarter and Full Year 2025 Financial Results
NewsMar 5, 6:11 AM ET
Earnings Scheduled For March 5, 2026
NewsMar 4, 2:01 PM ET
An Overview of Evogene's Earnings
Press releaseFeb 25, 8:00 AM ETPRNewswire
Evogene Releases CEO Letter to Shareholders
Press releaseFeb 19, 8:00 AM ETPRNewswire
Evogene Schedules Fourth Quarter and Full Year 2025 Financial Results Release
Press releaseFeb 17, 8:00 AM ETPRNewswire
Evogene and Queensland University of Technology (QUT) Announce a Collaboration to Advance AI-Driven Cancer Therapeutics
Press releaseFeb 11, 8:00 AM ETPRNewswire
Evogene, Systasy and LMU University Hospital Munich Announce a Collaboration to Develop Novel Therapies for Neutrophil-Derived Inflammatory Diseases
NewsNov 20, 6:11 AM ET
Earnings Scheduled For November 20, 2025
NewsNov 19, 11:03 AM ET
What's Next: Evogene's Earnings Preview
Press releaseAug 19, 7:00 AM ETPRNewswire
Evogene Reports Second Quarter 2025 Financial Results
NewsAug 18, 11:02 AM ET
Preview: Evogene's Earnings
NewsJun 10, 1:59 PM ETAvi Kapoor
Dow Gains 50 Points; US Small Business Optimism Index Rises In May
Press releaseMay 21, 7:00 AM ETPRNewswire
Evogene Reports First Quarter 2025 Financial Results
Press releaseMar 6, 7:15 AM ETPRNewswire
Evogene Reports Fourth Quarter and Full Year 2024 Financial Results

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Evogene to Participate in U.S. East Coast AI Drug Discovery Roadshow Organized by the Israel Export Institute and TradeIL

Evogene and Pure Capital Group Reach Cooperation Agreement to Resolve Differences and Reconstitute Board of Directors

Evogene Reports Nasdaq Grants Additional 180-Day Period to Regain Minimum Bid Price Compliance

Evogene Responds to Dissident Shareholders: Transformation and Commercial Progress Provide a Clear Path Forward

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Evogene Ltd. Shareholders Vote "FOR" the Company's Slate of Highly Qualified Director Nominees

Evogene Reports Second Quarter and First Half 2026 Financial Results

Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation

12 Health Care Stocks Moving In Monday's Pre-Market Session

Evogene Schedules Second Quarter 2026 Financial Results Release

Evogene Ltd. and ELEO Inc. Announce Collaboration to Develop Next-Generation Oral Small-Molecule PCSK9 Pathway Inhibitors for Hyperlipidemia and Cardiovascular Diseases

12 Health Care Stocks Moving In Wednesday's After-Market Session

AgPlenus Launches Novel AI Model for Predicting Antifungal Potency, Expanding ChemPass AI for Ag™ Capabilities

Evogene and Tel Aviv University's Blavatnik Center for Drug Discovery Announce Joint Initiative to Accelerate AI-Driven Small-Molecule Drug Discovery

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Evogene Announces Major Milestone in Its Collaboration with Google Cloud, Advancing ChemPass AI™ Toward Autonomous Small Molecule Discovery and Optimization

Full Transcript: Evogene Q1 2026 Earnings Call

Evogene to Present Its Pharma Division Achievements at the BIO International Convention

Evogene Announces Successful Completion of Phase 1 Clinical Study of BMC128, a Rationally Designed Live Bacterial Product, in Combination with Nivolumab by its Subsidiary Biomica

Earnings Scheduled For May 20, 2026

Evogene Reports First Quarter 2026 Financial Results

Evogene to Present at the 24th Schrödinger European User Group Meeting

Evogene Schedules First Quarter 2026 Financial Results Release

Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification

Casterra Announces Successful Commercial Field Trials in Brazil, Positioning Castor Oil as a Promising Candidate for Economically Viable Biofuel Feedstock

Evogene to Present Its Pharma Discovery Achievements at BIO-Europe Spring 2026

Evogene Earnings Review: Q4 Summary

Evogene Reports Fourth Quarter and Full Year 2025 Financial Results

Earnings Scheduled For March 5, 2026

An Overview of Evogene's Earnings

Evogene Releases CEO Letter to Shareholders

Evogene Schedules Fourth Quarter and Full Year 2025 Financial Results Release

Evogene and Queensland University of Technology (QUT) Announce a Collaboration to Advance AI-Driven Cancer Therapeutics

Evogene, Systasy and LMU University Hospital Munich Announce a Collaboration to Develop Novel Therapies for Neutrophil-Derived Inflammatory Diseases

Earnings Scheduled For November 20, 2025

What's Next: Evogene's Earnings Preview

Evogene Reports Second Quarter 2025 Financial Results

Preview: Evogene's Earnings

Dow Gains 50 Points; US Small Business Optimism Index Rises In May

Evogene Reports First Quarter 2025 Financial Results

Evogene Reports Fourth Quarter and Full Year 2024 Financial Results